Healy BC - Search Results

1

Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis.

Bargiela D, Bianchi MT, Westover MB, Chibnik LB, Healy BC, De Jager PL, Xia Z. Bargiela D, et al. Among authors: healy bc. Neurology. 2017 Feb 14;88(7):677-684. doi: 10.1212/WNL.0000000000003612. Epub 2017 Jan 13. Neurology. 2017. PMID: 28087821 Free PMC article.

2

Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL. Bakshi R, et al. Among authors: healy bc. Arch Neurol. 2008 Nov;65(11):1449-53. doi: 10.1001/archneur.65.11.1449. Arch Neurol. 2008. PMID: 19001162 Free PMC article.

3

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S; International Multiple Sclerosis Genetics Consortium; De Jager PL, Wicker LS, Todd JA, Hafler DA. Maier LM, et al. PLoS Genet. 2009 Jan;5(1):e1000322. doi: 10.1371/journal.pgen.1000322. Epub 2009 Jan 2. PLoS Genet. 2009. PMID: 19119414 Free PMC article.

4

Unbiased treatment effect estimates by modeling the disease process of multiple sclerosis.

Healy BC, Hayden DL, Sampat MP, Bakshi R, Guttmann CR. Healy BC, et al. J Neurol Sci. 2009 Mar 15;278(1-2):54-9. doi: 10.1016/j.jns.2008.11.013. Epub 2009 Jan 1. J Neurol Sci. 2009. PMID: 19121526

5

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Gorman MP, et al. Among authors: healy bc. Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505. Arch Neurol. 2009. PMID: 19139299

6

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Maier LM, Anderson DE, Severson CA, Baecher-Allan C, Healy B, Liu DV, Wittrup KD, De Jager PL, Hafler DA. Maier LM, et al. J Immunol. 2009 Feb 1;182(3):1541-7. doi: 10.4049/jimmunol.182.3.1541. J Immunol. 2009. PMID: 19155502 Free PMC article.

7

Modeling disease-state transition heterogeneity through Bayesian variable selection.

Healy BC, Engler D. Healy BC, et al. Stat Med. 2009 Apr 30;28(9):1353-68. doi: 10.1002/sim.3545. Stat Med. 2009. PMID: 19206077

8

Smoking and disease progression in multiple sclerosis.

Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, Buckle G, Houtchens M, Stazzone L, Moodie J, Berger AM, Duan Y, Bakshi R, Khoury S, Weiner H, Ascherio A. Healy BC, et al. Arch Neurol. 2009 Jul;66(7):858-64. doi: 10.1001/archneurol.2009.122. Arch Neurol. 2009. PMID: 19597087 Free PMC article.

9

A method for evaluating treatment switching criteria in multiple sclerosis.

Healy BC, Glanz BI, Stankiewicz J, Buckle G, Weiner H, Chitnis T. Healy BC, et al. Mult Scler. 2010 Dec;16(12):1483-9. doi: 10.1177/1352458510379245. Epub 2010 Aug 24. Mult Scler. 2010. PMID: 20736245

10

A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.

Khoury SJ, Healy BC, Kivisäkk P, Viglietta V, Egorova S, Guttmann CR, Wedgwood JF, Hafler DA, Weiner HL, Buckle G, Cook S, Reddy S. Khoury SJ, et al. Among authors: healy bc. Arch Neurol. 2010 Sep;67(9):1055-61. doi: 10.1001/archneurol.2010.222. Arch Neurol. 2010. PMID: 20837847 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters